Infective Endocarditis in People Who Inject Drugs: Reoperation, Stigma and the Limits of a Purely Surgical Answer
DOI:
https://doi.org/10.5281/zenodo.22345352Abstract
When a person who injects drugs (PWID) is admitted with infective endocarditis, the clinical conversation often narrows
quickly to a single question: does this valve need surgery. That framing is not wrong, but it is incomplete. The literature
reviewed here shows that even a technically successful operation leaves PWID with worse long-term survival and a
substantially higher chance of needing a second operation than non-PWID patients undergoing the identical procedure, and
that the largest, most modifiable outcome gaps in this population sit upstream and downstream of the operating
room, not inside it.
References
Goodman-Meza D, Weiss RE, Gamboa S, et al. "Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis". BMC Infect Dis 19(2019):918.
Kimmel SD, Walley AY, Li Y, et al. "Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study". Clin Infect Dis 73(2021):e2484-e2492.
[Authors not independently confirmed beyond the indexed abstract]. "Impact of MOUD Initiation in Patients With Injection Drug Use-Associated Infective Endocarditis". Open Forum Infect Dis 13(2026):ofag288.
[Authors not independently confirmed beyond the indexed abstract]. "Trends in the Management of Infective Endocarditis for Patients Who Inject Drugs: A Survey of Healthcare Facilities in Tennessee". Open Forum Infect Dis 12(2025):ofaf150.
